Amanta Healthcare Ltd, Fundamental analysis

Industry Industry name	Pharmaceuticals
Variance Full Year Net Profit Variance	55
Equity Latest Equity	38.83
Face Value Latest Face Value	10
Reserves Total Reserve	181.38
Dividend Full Year Dividend %	0
Sales Turnover Full Year Net Sales	287.68
Net Profit Full Year Net Profit	16.37
Full Year CPS Full Year Cash Per Share	9
Earning Per Share Full Year Earning Per Share	4.2
Quarter CPS Latest quarter Cash Per Share	0
Latest Quarter Date Latest Quarter Yrc	Jun 1, 2026
Latest Quarter Sales Latest Quarter Net Sales	68.8
Previous EPS Previous earnings per share	0
Book Value Book value	56.7
Networth Full Year Return on Networth	10.34
Price/Book Value Price to Book value	3.439153
Yearly PE ratio Full Year Price to Earning per share	46.3
Yearly PC ratio Full Year Price to Cash Per Share	21.6
Bse value BSE Value in lakhs	2.3
Nse value NSE Value in lakhs	21.99
High 52 week high	205
Low 52 week low	93
Price NSE Current market price	194
CPM Current market price	195

Market cap BSE / NSE Market Cap	756.4
Net profit Latest Quarter Net Profit	3.31
Net profit variance Latest Quarter Net Profit variance	-6
Result year Trailing latest month	Jun 1, 2026
TTM Sales Trailing Twelve 12 month Net Sales	0
TTM OP Trailing Twelve 12 month Operating Profit	0
TTM OPM Trailing Twelve 12 month Operating Profit Margin	0
TTM GP Trailing Twelve 12 month Gross Profit	39.46
TTM GPM Trailing Twelve 12 month Gross Profit Margin	13.55
TTM NP Trailing Twelve 12 month Net Profit	0
TTM NPV Trailing Twelve 12 month Net Profit Variane	-4.15
TTM EPS Trailing Twelve 12 month EPS	3.95
TTM PE Trailing Twelve 12 month PE	49.32
TTM CPS Trailing Twelve 12 month CPS	0
Month CPS Month Cash Per Share	0
TTM Depreciation Trailing Twelve 12 month Depreciation	0
Equity Latest Equity	38.83
LTP Latest Price (BSE/NSE)	195
Gross block Latest Gross Block	277.48
Loans Total loans	25.54
Advances Latest Advances for Banks	0
Net profit asset Latest Assets	0
Year OPM Full Year Operating Profit Margin	20.8
Year GPM Full Year Gross Profit Margin	14.7
Quarter OPM Latest quater Operation Profit Margin	21.1

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
+ Sales	67	68	72	65	71	74	77	69
YOY Sales Growth %				-4%	6%	10%	7%	5%
Gross Sales	67	68	72	65	71	74	77	69
+ Expenses	53	53	53	50	59	59	62	54
Material Cost %	38%	62%	44%	50%	36%	33%	32%	40%
Raw Material Cost	23	30	26	24	24	24	25	23
Change in Inventory	2	12	6	9	2	0	0	5
Manufacturing Cost %	30%	32%	27%	34%	35%	29%	29%	32%
Employee Cost %	13%	14%	13%	16%	15%	15%	14%	17%
Other Cost %	-2%	-30%	-10%	-22%	-3%	2%	5%	-10%
Raw Materials %	34%	44%	36%	36%	33%	33%	33%	33%
Purchase of Finished Goods %	5%	5%	6%	5%	2%	3%	5%	4%
Stock Adjustments %	-3%	-17%	-8%	-13%	-3%	-0%	0%	-7%
Other Manufacturing Expenses %	30%	32%	27%	34%	35%	29%	29%	32%
Operating Profit	14	15	19	15	12	15	15	15
OPM %	21%	22%	26%	23%	17%	21%	19%	21%
+ Other Income	0	1	0	1	0	1	2	1
Miscellaneous Income	0	1	0	1	0	1	2	1
Interest	6	6	6	6	5	5	4	6
Depreciation	5	5	5	5	5	5	5	5
Profit before tax	3	6	8	5	2	6	8	4
+ Tax %	29%	23%	27%	29%	47%	27%	27%	26%
Current Tax	1	1	2	2	2	2	3	0
Deferred Tax	0	0	0	0	-1	0	-1	1
+ Net Profit	2	4	6	4	1	5	6	3
Extraordinary Income / Expense	0	0	0	0	-3	0	0	0
Exceptional Item	0	0	0	0	-3	0	0	0
EPS in Rs

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Sales	184	171	225	259	280	275	288
Sales Growth %		-7%	32%	15%	8%	-2%	5%
Gross Sales						275	288
+ Expenses	155	162	198	205	188	213	230
Material Cost %	35%	29%	34%	39%	25%	21%	20%
Raw Material Cost	68	64	89	101	53	77	68
Change in Inventory	-4	-14	-12	1	17	-20	-11
Manufacturing Cost %	20%	19%	19%	23%	30%	30%	31%
Employee Cost %	18%	20%	18%	12%	12%	13%	15%
Other Cost %	12%	27%	18%	4%	1%	13%	15%
Raw Materials %	37%	37%	40%	39%	19%	28%	24%
Purchase of Finished Goods %						4%	4%
Stock Adjustments %	2%	8%	5%	-0%	-6%	7%	4%
Power & Fuel %	10%	8%	8%	9%	9%	8%	8%
Other Manufacturing Expenses %	10%	10%	11%	14%	21%	22%	23%
Selling & Administration %	5%	6%	4%	4%	12%	13%	12%
Miscellaneous Expenses %	3%	4%	2%	1%	1%	1%	2%
Operating Profit	30	10	27	54	92	61	57
OPM %	16%	6%	12%	21%	33%	22%	20%
+ Other Income	2	1	76	4	1	1	3
Miscellaneous Income						1	3
Interest	38	40	49	35	34	28	21
Depreciation	16	17	17	18	20	18	19
Profit before tax						16	21
+ Tax %						26%	30%
Current Tax	4	4	7	-1	4	4	9
Deferred Tax	0	0	0	6	-2	1	-2
+ Net Profit						12	15
Profit Growth %							23%
Extraordinary Income / Expense						0	-3
Exceptional Item						0	-3
EPS in Rs

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	27	27	37	38	38	40	39
Reserves	2	-20	36	36	39	68	181
+ Borrowings	231	235	216	205	200	193	244
Secured Borrowings	216	185	201	191	168	159	219
Unsecured Borrowings	15	50	14	14	32	34	26
+ Other Liabilities	127	150	104	96	75	81	93
Current Liabilities	73	85	99	89	78	84	97
Provisions	3	3	11	8	8	9	14
Other liability items	54	65	5	7	0	0	0
Total Liabilities	388	392	392	374	352	382	558
+ Fixed Assets	244	242	240	232	228	217	207
Gross Block	395	399	414	249	279	269	277
Accumulated Depreciation	152	157	175	17	51	52	70
CWIP	0	0	0	9	0	7	82
Investments	0	2	3	0	4	8	7
+ Other Assets	144	149	149	133	120	150	262
Inventories	39	57	71	69	59	73	83
Trade receivables	52	51	45	54	48	50	43
Cash Equivalents	6	9	10	4	4	3	93
Loans n Advances	7	12	7	5	10	14	24
Other asset items	39	20	16	2	-1	9	20
Total Assets	388	392	392	374	352	382	558

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Cash from Operating Activity	38	31	62	43	58	47	48
Profit Before Tax & Extraordinary Items	-15	-18	62	3	5	15	21
Depreciation	16	17	17	18	20	18	19
Interest (Net)	38	40	49	35	33	28	19
Profit / Loss on Sale of Assets	0	0	0	0	0	0	0
Provisions & Write-offs (Net)	0	0	0	0	1	1	1
Profit / Loss in Forex	0	0	0	-1	0	0	-1
Receivables	0	-3	5	-10	5	-1	7
Inventories	-1	-18	-14	2	9	-14	-10
Trade Payables	-5	8	14	0	-11	6	5
Loans & Advances	0	0	0	0	0	0	0
Interest Paid (Net)	0	-1	0	0	0	0	0
Direct Taxes Paid	0	5	0	-6	-6	-4	-7
Extraordinary Items	0	0	-75	0	0	0	0
+ Cash from Investing Activity	-9	-13	-6	-7	-10	-24	-94
Purchase of Fixed Assets	-11	-13	-10	-6	-13	-21	-80
Sale of Fixed Assets	0	2	0	0	1	0	0
Purchase of Investments	0	0	0	0	0	-4	-4
Sale of Investments	0	0	0	0	0	0	5
Interest Received	0	1	0	0	0	0	1
Others	1	-2	4	0	1	-1	-15
+ Cash from Financing Activity	-37	-18	-50	-42	-46	-23	126
Proceeds from Issue of Shares	0	0	0	0	0	20	126
Proceeds from Issue of Debentures	0	0	0	8	0	0	0
Proceeds from Other Long-Term Borrowings	1	4	162	0	27	126	77
Proceeds from Deposits	0	0	0	0	6	2	1
Redemption of Debentures	0	0	0	-2	-35	-122	0
Repayment of Long-Term Borrowings	-19	0	-171	-17	-10	-19	-19
Repayment of Financial Liabilities	0	0	0	-2	-3	-2	-2
Dividend Paid	0	0	0	-1	-1	-1	0
Others	0	0	0	-1	-5	-6	-38
Net Cash Flow	-8	0	6	-6	1	-1	81